Encompass Health (EHC) — insider trading
Health Care
Encompass Health (EHC) has 17 reported SEC Form 4 insider transactions in our data, including 3 open-market sales among the most recent 17 (latest 2026-07-16).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-16 | Christie Edward M III | Director | Grant / award / vesting | 248 | $112.43 | $27.9K | Form 4 |
| 2026-07-16 | Reidy Christopher R | Director | Grant / award / vesting | 319 | $112.40 | $35.9K | Form 4 |
| 2026-07-15 | CARMICHAEL GREG D | Director | Grant / award / vesting | 29 | $0.00 | $0 | Form 4 |
| 2026-07-15 | Hayes Cain A | Director | Grant / award / vesting | 4 | $0.00 | $0 | Form 4 |
| 2026-07-15 | HERMAN JOAN E | Director | Grant / award / vesting | 85 | $0.00 | $0 | Form 4 |
| 2026-07-15 | KATZ LESLYE G | Director | Grant / award / vesting | 85 | $0.00 | $0 | Form 4 |
| 2026-07-15 | O'Connor Kevin J. | Director | Grant / award / vesting | 19 | $0.00 | $0 | Form 4 |
| 2026-07-15 | SCHLICHTING NANCY M | Director | Grant / award / vesting | 40 | $0.00 | $0 | Form 4 |
| 2026-07-15 | Williams Terrance | Director | Grant / award / vesting | 29 | $0.00 | $0 | Form 4 |
| 2026-07-15 | Christie Edward M III | Director | Grant / award / vesting | 11 | $0.00 | $0 | Form 4 |
| 2026-07-15 | Reidy Christopher R | Director | Grant / award / vesting | 21 | $0.00 | $0 | Form 4 |
| 2026-05-15 | COLTHARP DOUGLAS E | Officer (EVP & Chief Financial Officer) | Option exercise / conversion (derivative) | 27,694 | $0.00 | $0 | Form 4 |
| 2026-05-15 | COLTHARP DOUGLAS E | Officer (EVP & Chief Financial Officer) | Open-market sale | 1 | $107.28 | $107 | Form 4 |
| 2026-05-15 | COLTHARP DOUGLAS E | Officer (EVP & Chief Financial Officer) | Open-market sale | 27,693 | $106.83 | $2.96M | Form 4 |
| 2026-05-15 | COLTHARP DOUGLAS E | Officer (EVP & Chief Financial Officer) | Option exercise / conversion | 27,694 | $32.94 | $912.2K | Form 4 |
| 2026-05-11 | Tuer Patrick William | Officer (EVP, Chief Operating Officer) | Open-market sale | 682 | $104.56 | $71.3K | Form 4 |
| 2026-05-07 | O'Connor Kevin J. | Director | Grant / award / vesting | 1,634 | $0.00 | $0 | Form 4 |
Ask the chat about EHC's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Encompass Health (EHC).
Last updated 2026-07-16 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.